Sobel Alan D.'s Form 4 filing
Cytosorbents Corp (CTSO) · filed Sep 16, 2026
- Accession no.
- 0001104659-26-108246
- Filed
- Sep 16, 2026, 4:05 PM ET
- Trade date
- Sep 15, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $15.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sobel Alan D.CIK 0001639386 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | PPurchaseAcquired | +1,900 | $6.12 | +$11,628 | 9,287 | Direct | |
| Sep 15, 2026 | Common Stock | PPurchaseAcquired | +500 | $6.05 | +$3,025 | 9,787 | Direct | |
| Sep 15, 2026 | Common Stock | PPurchaseAcquired | +100 | $6.01 | +$601 | 9,887 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.